NCT00574470View on ClinicalTrials.gov

Anti Cytokine Combination Therapy With Daclizumab and Infliximab for Treatment of Steroid Refractory Acute GVHD

PHASE4CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

August 31, 2008

Conditions
Graft vs Host Disease
Interventions
DRUG

daclizumab, infliximab

Daclizumab 1 mg/kg IV days 1, 4, 8, 15 and 22. Infliximab 10 mg/kg IV days 1, 8, 15 and 22.

Trial Locations (1)

52242

University of Iowa Hospitals, Iowa City

All Listed Sponsors
lead

University of Iowa

OTHER

NCT00574470 - Anti Cytokine Combination Therapy With Daclizumab and Infliximab for Treatment of Steroid Refractory Acute GVHD | Biotech Hunter | Biotech Hunter